Adam El Din Email & Phone Number

Bougy-Villars, Vd, Ch

Switzerland

Geneva Area, Switzerland

Achievements:Hired by ZRG Partners in 2012 to build and lead the Global Life Sciences Practice as well as the European organizationMerged successfully the Life Science teams of two of the best Executive Search Boutiques GloballyInitiated and Led the efforts in building the ZRG Partners Life Science PracticeBuilt strong relationships with the Leaders of some of the largest Life Science companiesFacilitated the global collaboration between our consultants Built on a unique… Show more Achievements:Hired by ZRG Partners in 2012 to build and lead the Global Life Sciences Practice as well as the European organizationMerged successfully the Life Science teams of two of the best Executive Search Boutiques GloballyInitiated and Led the efforts in building the ZRG Partners Life Science PracticeBuilt strong relationships with the Leaders of some of the largest Life Science companiesFacilitated the global collaboration between our consultants Built on a unique team work mentality at ZRG Partners that encourages collaboration and partnerships. Managed and executed high profile global searches in Europe, USA and AsiaBuilt R&D, Regulatory and Medical Affairs departments for our partners in particular in immunology & oncologyExecuted with over 90% placement rate some of the highest profile searches globally#1 performer at ZRG Partners for several yearsBuilt strong partnerships with Pharmaceutical, Biotechnology, Medical Device and Medical Services companiesFinalized global agreements with our partners. Maintained partnerships for over 10 years and carried on my KCI relationships till today. Participated in the phenomenal growth of ZRG Partners over the last 10 years Show less

Turned around a European operation to be the most profitable region for Ken Clark International over the last 4 years.o One of the most successful consultants at KCIo Best performer globally at KCI from 2008-2011o Established a strong collaboration with our consultants in the USA, APAC and MEo Built on our global relationshipso Established several Global preferred supplier agreements for KCIo Established KCI as a one of the most respected Search Firms in Life… Show more Turned around a European operation to be the most profitable region for Ken Clark International over the last 4 years.o One of the most successful consultants at KCIo Best performer globally at KCI from 2008-2011o Established a strong collaboration with our consultants in the USA, APAC and MEo Built on our global relationshipso Established several Global preferred supplier agreements for KCIo Established KCI as a one of the most respected Search Firms in Life Sciences Globallyo Built a top class recruiting and research teamo Achieved one of the highest placement rates at KCIo Retention of partnerships for periods of over 5 yearso Accounted for more than 50% of KCI profitability in 2 of the last 6 yearso Established privileged working relationships with Executive Line Managers and Human Resources in most of the prestigious Life Science companies Globally Show less

Responsible for Switzerland, France, Italy, Spain and the Nordic countries

Switzerland

• Responsible for Worldwide Marketing & Sales activities• Built a Marketing and Medical Team that over-achieved on a yearly basis• Responsible for Global Medical Affairs• Responsible for Market Access (an invited guest for several NICE submissions)• Launched our technology in 47 countries• Established privileged contacts with KOLs all over the world• Participated in improving the technical aspects of our products• Negotiated licensing agreements with potential… Show more • Responsible for Worldwide Marketing & Sales activities• Built a Marketing and Medical Team that over-achieved on a yearly basis• Responsible for Global Medical Affairs• Responsible for Market Access (an invited guest for several NICE submissions)• Launched our technology in 47 countries• Established privileged contacts with KOLs all over the world• Participated in improving the technical aspects of our products• Negotiated licensing agreements with potential partners• Established our technology as the safest and most effective product on the market• Initially also responsible for QA, Clinicals & Regulatory Affairs• Initiated and negotiated potential acquisitions with some of the largest Global Companies Show less

Responsible for Medical, Clinical & Regulatory Affairs in Europe. Involved with US Regulatory submissionsInitiated clinical trials for 6 new indications.Obtained product approvals in Europe (4 indications) and Asia (2 indications)Participated in obtaining 510(K) approvals for 3 indicationsInitiated and attended a major pre-IDE meeting with the FDAStrong collaboration with the USA for FDA approvals (PMAs & 510(K)sEstablished very strong relationships with KOL in… Show more Responsible for Medical, Clinical & Regulatory Affairs in Europe. Involved with US Regulatory submissionsInitiated clinical trials for 6 new indications.Obtained product approvals in Europe (4 indications) and Asia (2 indications)Participated in obtaining 510(K) approvals for 3 indicationsInitiated and attended a major pre-IDE meeting with the FDAStrong collaboration with the USA for FDA approvals (PMAs & 510(K)sEstablished very strong relationships with KOL in cardiology, radiology, urology and gastroenterology Show less

Switzerland

Established the Wallsten as the best available permenant stent in the non vascular indicationsLaunched the wallstent in 7 new indications within 2 yearsCreated a world class team of sales managers to run this new businessWallstent endoprostheses for the relief of prostatic urethral obstruction in high risk patientsA. Adamcorrespondence, R. Jäger, J. McLoughlin, A. El-Din, L. Machan, G. Williams, D.J. Allison

Medical Device Division

When I joined in 1985, the company (Medinvent that was later aquired by Pfizer) was concentrating on one indication. I was involved with the first ever human coronary stent implantation.In addition I identified and developed some of the most successful indications of the Wallstent in particular in the biliary and urological applications.Participated in negotiations with potential partnersWallstent endoprostheses for the relief of prostatic urethral obstruction in high risk… Show more When I joined in 1985, the company (Medinvent that was later aquired by Pfizer) was concentrating on one indication. I was involved with the first ever human coronary stent implantation.In addition I identified and developed some of the most successful indications of the Wallstent in particular in the biliary and urological applications.Participated in negotiations with potential partnersWallstent endoprostheses for the relief of prostatic urethral obstruction in high risk patients. Adam, A; Jäger, R; McLoughlin, J; el-Din, A; Machan, L; Williams, G; Allison, DJ; (1990) Wallstent endoprostheses for the relief of prostatic urethral obstruction in high risk patients. Clin Radiol , 42 (4) pp. 228-232. Show less

Executive Course, Mobilizing People

Research, Business

Medical School

Gce, Science